Supplements

ULORIC Product Information Guide March 2011 03-2011 Digital Edition

View This Supplement

Oncology March 2013
03-2013

Supplement Articles

Uloric Product Information Guide March 2011 3/17/2011

Gout is the most common form of arthritis and affects 6.1 million Americans. The primary underlying cause of gout is hyperuricemia. ULORIC 40 mg or 80 mg is approved for the treatment of hyperuricemia in patients with gout. Click here for PDF.

Past Supplements

View this Supplement

Oncology January 2013
01-2013

View this Supplement

Oncology November 2012
11-2012

View this Supplement

Oncology September 2012
09-2012

View this Supplement

Oncology July 2012
07-2012

View this Supplement

BYDUREON Product Information Guide 2012
06-2012

View this Supplement

Generic Drug Review June 2012
06-2012

View this Supplement

Diabetes May 2012
05-2012

View this Supplement

Oncology May 2012
05-2012

Advertisers Media Kit Contact Us Privacy Policy Editorial Staff

Classifieds About USP

U.S. Pharmacist is a monthly journal dedicated to providing the nation's pharmacists with up-to-date, authoritative, peer-reviewed clinical articles relevant to contemporary pharmacy practice in a variety of settings, including community pharmacy, hospitals, managed care systems, ambulatory care clinics, home care organizations, long-term care facilities, industry and academia. The publication is also useful to pharmacy technicians, students, other health professionals and individuals interested in health management. Pharmacists licensed in the U.S. can earn Continuing Education credits through Postgraduate Healthcare Education, LLC, accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

Copyright © 2000 - 2013 Jobson Medical Information LLC unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.